Effect of Vyvanse on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD)
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
This study involves research to test how Vyvanse (study drug) affects sleep in 24 children
aged 6 to 12 years who have ADHD. Vyvanse is approved by the FDA for the treatment ADHD of in
children aged 6 to 12 years. The experimental part of this study is to determine how Vyvanse
affects sleep.